Form D · Biotechnology
CanniMed Therapeutics Inc.
Saskatoon, A9 · CIK 0001695631
Offering snapshot reported Jan 30, 2017 · SEC filing
- Reported sold
- $5.15M Offering amount: $5.15M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $250K Reported outside-investor minimum
- First sale
- Dec 29, 2016 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 30, 2017 | Initial | $5,153,257 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $310K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-279555
The transactions were in Canadian dollars initially and have been converted to U.S. dollars for this Item 13. The exchange rate as of December 21, 2016 was Canadian $1.00 = U.S. $0.7462, and the amount sold in Canadian dollars was $6,906,000.
The figure estimated for sales commissions is 6% of the total amount sold in Item 13.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Haywood Securities Inc. | None | Haywood Securities (USA) Inc. · CRD 42072 |
| AltaCorp Capital Inc. | None | AltaCorp Capital (USA) Inc. · CRD 155053 |
Source: Form D, filed Jan 30, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gulwant Bajwa | Executive |
| Doug Banzet | Director |
| Donald Ching | Director |
| Rob Duguid | Director |
| Marianne Greer | Director |
| Larry Holbrook | Executive |
| Richard Hoyt | Director |
| John Knowles | Director, Executive |
| Dwayne Lashyn | Director |
| Bruce Mackler | Director |
| Brandon Price | Director |
| Brenton Zettl | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1 Plant Technology Road Box 19 A, Rr#5
Saskatoon, A9, S7K 3J8
Saskatoon, A9, S7K 3J8